Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices 48745 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name Number of 

respondents 

Number of 

responses per 

respondent * 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Kidney Transplant Recipient Registration ........................... 237 89.43 21,195 1.20 25,434 

Kidney Transplant Recipient Follow-Up 6 Month—5 Year .. 237 431.86 102,351 0.90 92,116 

Kidney Transplant Recipient Follow-Up Post 5 Year .......... 237 449.40 106,508 0.50 53,254 

Kidney Post-Transplant Malignancy Form ........................... 237 22.64 5,366 0.80 4,293 

Pancreas Transplant Candidate Registration ...................... 133 2.77 368 0.60 221 

Pancreas Transplant Recipient Registration ....................... 133 1.46 194 1.20 233 

Pancreas Transplant Recipient Follow-Up 6 Month—5 

Year .................................................................................. 133 7.87 1,047 0.50 523 

Pancreas Transplant Recipient Follow-Up Post 5 Year ...... 133 15.93 2,119 0.50 1,059 

Pancreas Post-Transplant Malignancy Form ...................... 133 0.73 97 0.60 58 

Kidney/Pancreas Transplant Candidate Registration .......... 133 9.75 1,297 0.60 778 

Kidney/Pancreas Transplant Recipient Registration ........... 133 7.73 1,028 1.20 1,234 

Kidney/Pancreas Transplant Recipient Follow-Up 6 

Month—5 Year ................................................................. 133 32.80 4,362 0.50 2,181 

Kidney/Pancreas Transplant Recipient Follow-Up Post 5 

Year .................................................................................. 133 57.80 7,687 0.60 4,612 

Kidney/Pancreas Post-Transplant Malignancy Form .......... 133 2.20 293 0.40 117 

VCA Transplant Candidate Registration .............................. 27 0.89 24 0.40 11 

VCA Transplant Recipient Registration ............................... 27 1.59 43 1.36 c 58 

VCA Transplant Recipient Follow Up .................................. 27 0.67 18 1.31 d 24 

Organ Labeling and Packaging ........................................... 57 208.25 11,870 0.18 2,137 

Organ Tracking and Validating ............................................ 34 169.06 5,748 0.08 460 

Kidney Paired Donation Candidate Registration ................. 160 1.38 221 0.29 64 

Kidney Paired Donation Donor Registration ........................ 160 1.46 234 1.07 250 

Kidney Paired Donation Match Offer Management ............. 160 1.51 242 0.67 162 

Disease Transmission Event ............................................... 308 1.44 444 0.62 275 

Living Donor Event .............................................................. 251 0.12 30 0.56 17 

Safety Situation .................................................................... 450 0.48 216 0.56 121 

Potential Disease Transmission .......................................... 57 6.88 392 1.27 498 

Request to Unlock ............................................................... 450 39.22 17,649 0.02 353 

Total .............................................................................. 8,290 ........................ 604,519 ........................ 437,240 

* The Number of Responses per Respondent was calculated by dividing the Total Responses by the Number of Respondents and rounding to 

the nearest tenth. aTotal burden increased due to the approval of the ‘‘Modify Data Collection on VCA Living Donors’’ proposal approved by the OPTN Board of 

Directors (BOD) in December of 2020. The proposal required adding 54 new data fields onto this form and removing 1 data field from this form. bTotal burden increased due to the approval of the ‘‘Modify Data Collection on VCA Living Donors’’ proposal approved by the OPTN BOD in 

December of 2020. The proposal required adding 17 new data fields onto this form. cTotal burden increased due to the approval of the ‘‘Programming VCA Allocation in UNet’’ proposal approved by the OPTN BOD in December of 2020. The proposal required adding 16 new data fields onto this form and removing 10 data fields from this form. dTotal burden increased due to the approval of the ‘‘Programming VCA Allocation in UNet’’ proposal approved by the OPTN BOD in December of 2020. The proposal required adding 54 new data fields onto this form and removing 5 data fields from this form. 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–18688 Filed 8–30–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Establishment of the Office of Climate 

Change and Health Equity 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

Statement of Organization, Functions, 

and Delegations of Authority 

Part A, Office of the Secretary, 

Statement of Organization, Function, 

and Delegation of Authority for the U.S. 

Department of Health and Human 

Services (HHS) is being amended at 

Chapter AC, Office of the Assistant 

Secretary for Health (OASH), as last 

amended at 75 FR 53304, dated August 

31, 2010, and 72 FR 58095–96, dated 

October 12, 2007. Executive Order 

14008, Tackling the Climate Crisis at 

Home and Abroad, section 222(d), 

directs the Secretary of Health and 

Human Services to establish an Office of 

Climate Change and Health Equity to 

address the impact of climate change on 

the health of the American people. This 

amendment reflects the establishment of 

an office to address the impact of 

climate change on the health of the 

American people and to empower 

individuals through information, data, 

and scientific approaches to pursue 

environmental justice. Specifically, this 

notice establishes the Office of Climate 

Change and Health Equity in the OASH. 

The changes are as follows: 

A. Under Part A, Chapter AC, under 

the Office of the Assistant Secretary for 

Health, add the following: 

1. The Office of Climate Change and 

Health Equity (OCCHE), is headed by a 


khammond on DSKJM1Z7X2PROD with NOTICES
48746 Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices 

Director who reports to the Assistant 

Secretary for Health. 

2. OCCHE shall work with the 

Immediate Office of the Secretary, Staff 

Divisions, and Operating Divisions to 

focus on: 

—Identifying communities with 

disproportionate exposures to climate 

hazards and vulnerable populations. 

—Addressing health disparities 

exacerbated by climate impacts to 

enhance community health resilience. 

—Promoting and translating research on 

public health benefits of multisectoral climate actions. 

—Supporting regulatory efforts to 

reduce greenhouse gas emissions and 

criteria air pollution throughout the 

health care sector, including 

participating suppliers and providers. 

—Fostering innovation in climate 

adaptation and resilience for people 

and communities experiencing a 

disproportionate share of climate 

impacts and health inequities. 

—Providing expertise and coordination 

to the White House and other Federal 

agencies related to climate change and 

health equity deliverables and 

activities, including executive order 

implementation, and reporting on 

health adaptation actions under the 

United Nations Framework 

Convention on Climate Change. 

—Promoting training opportunities to 

build the climate and health 

workforce and empower 

communities. 

—Exploring opportunities to partner 

with the philanthropic and private 

sectors to support innovative 

programming to address disparities 

and health sector transformation. 

Delegations of Authority 

Directives or orders made by the 

Secretary or the Assistant Secretary for 

Health, including all delegations and redelegations of authority made to 

officials and employees of affected 

organizational components will 

continue in force pending further 

delegation, if allowed, provided they are 

consistent with this realignment. 

Andrea Palm, 

Deputy Secretary. 

[FR Doc. 2021–18794 Filed 8–30–21; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Center for 

Advancing Translational Sciences 

Advisory Council. 

The meeting will be open to the 

public as indicated below. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov). Individuals who 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Advisory 

Council. 

Date: September 23–24, 2021. 

Closed: September 23, 2021, 10:30 a.m. to 

12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Room 987/989, 

Bethesda, MD 20892 (Virtual Meeting). 

Open: September 23, 2021, 1:00 p.m. to 

5:00 p.m. 

Agenda: Report from the Institute Director 

and other staff. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Room 987/989, 

Bethesda, MD 20892 (Virtual Meeting). 

Open: September 24, 2021, 1:00 p.m. to 

5:00 p.m. 

Agenda: To view and discuss Clearance of 

Concepts. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Room 987/989, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, One 

Democracy Plaza, Room 1072, Bethesda, MD 

20892, 301–435–0809, anna.ramseyewing@

nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice no later than 15 days after the 

meeting at NCATSCouncilInput@

mail.nih.gov. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: August 25, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18727 Filed 8–30–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Evaluation of 

Office of Acquisitions System (OASYS) 

and FFRDC Contract Administration 

System (FCAS) Vendor Portals 

National Cancer Institute (NCI) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Marla Jacobson, 9609 Medical Center 

Drive, MSC 9742, Rockville, MD 20850 

or call non-toll-free number 240–276– 


khammond on DSKJM1Z7X2PROD with NOTICES